Randomized, Double-Blind, Placebo-Controlled Phase III Trial Comparing Docetaxel and Prednisone With or Without Bevacizumab in Men With Metastatic Castration-Resistant Prostate Cancer: CALGB 90401

PURPOSE: A randomized, placebo-controlled study based on preclinical and clinical data that supports the potential role of vascular endothelial growth factor in prostate cancer was performed to evaluate the addition of bevacizumab to standard docetaxel and prednisone therapy in patients with metasta...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Kelly, William Kevin, Halabi, Susan, Carducci, Michael, George, Daniel, Mahoney, John F., Stadler, Walter M., Morris, Michael, Kantoff, Philip, Monk, J. Paul, Kaplan, Ellen, Vogelzang, Nicholas J., Small, Eric J.
Format: Artigo
Idioma:Inglês
Publicat: American Society of Clinical Oncology 2012
Matèries:
Original Reports
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3383121/
https://ncbi.nlm.nih.gov/pubmed/22454414
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2011.39.4767
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars